Work

Patient-Reported Outcomes Among Patients with Triple-Class Refractory Multiple Myeloma in Real-World Clinical Practice: A Prospective, Multi-Site Observational Study

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-180984

Authors: Charalampos Charalampous, Shaji Kunnathu Kumar, Ricardo Parrondo, Saurabh Chhabra, Mei Sheng Duh, Priyanka Bobbili, Aolin Wang, Jingyi Chen, Manasi Mohan, Patrick Hlavacek, Jinma Ren, Alex Schepart, Guido Nador, Marco DiBonaventura

Institutions: Mayo Clinic, Mayo Clinic in Florida, Medical College of Wisconsin, Analysis Group (United States), Pfizer (United States), Pfizer (United Kingdom)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389230566

Cites:

Cited by: 2

Related to: 10